Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Teva withdraws proposal to acquire Mylan
Teva to sell Allergan's generics business in Ireland and UK for £603m
Teva Pharmaceuticals - Wikipedia
In Israel's largest acquisition, Teva buys Allergan Generics for $40.5b - The Jerusalem Post
Teva to sell Allergan's generics business in UK, Ireland for $769 million | Reuters
Teva's Acquisition Program A Winner (NYSE:TEVA) | Seeking Alpha
Teva, Allergan Tweak Acquisition Agreement - WSJ
As Teva claims initial stake, Mylan continues to refuse takeover advances | NASDAQ:TEVA
Net profits of Pliva, Barr, and Teva Pharmaeuticals before and after... | Download Scientific Diagram
Teva – Acquisitions and Growth 1995–2005. | Download Scientific Diagram
Teva Pharmaceuticals - Wikipedia
Israel's largest company acquisition: Teva buys Allergan Generics for $40.5 billion, new stage in Israeli business? | EIPA
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
TEVA buys Mexico's RIMSA for $2.3bn - PMLiVE
Teva Pharmaceuticals reports higher quarterly profits, sales
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Israel's Teva agrees to buy US smart inhaler firm Gecko Health Innovations - Pharmaceutical Technology
Teva's Acquisition Program A Winner (NYSE:TEVA) | Seeking Alpha
Teva to buy Auspex Pharmaceuticals in $3.5 billion deal
Teva Merger: Cephalon CEO Gets $5M for 3 Months' Work; Staff Gets Layoffs - CBS News
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
